Gershlick, A. H., Spriggins, D., Davies, S. W., Syndercombe Court, Y. D., Timmins, J., Timmis, A. D., . . . Balcon, R. (1994). Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: Results of a randomised placebo controlled trial.

Gershlick, A. H., D. Spriggins, S. W. Davies, Y. D. Syndercombe Court, J. Timmins, A. D. Timmis, M. T. Rothman, C. Layton, and R. Balcon. Failure of Epoprostenol (prostacyclin, PGI2) to Inhibit Platelet Aggregation and to Prevent Restenosis After Coronary Angioplasty: Results of a Randomised Placebo Controlled Trial. 1994.

Gershlick, A. H., et al. Failure of Epoprostenol (prostacyclin, PGI2) to Inhibit Platelet Aggregation and to Prevent Restenosis After Coronary Angioplasty: Results of a Randomised Placebo Controlled Trial. 1994.